Literature DB >> 34703025

Common and differential connectivity profiles of deep brain stimulation and capsulotomy in refractory obsessive-compulsive disorder.

Xiaoyu Chen1,2, Zhen Wang3,4, Qian Lv5, Qiming Lv3,4, Guido van Wingen6,7, Egill Axfjord Fridgeirsson6,7, Damiaan Denys6,7,8, Valerie Voon9, Zheng Wang10.   

Abstract

Neurosurgical interventions including deep brain stimulation (DBS) and capsulotomy have been demonstrated effective for refractory obsessive-compulsive disorder (OCD), although treatment-shared/-specific network mechanisms remain largely unclear. We retrospectively analyzed resting-state fMRI data from three cohorts: a cross-sectional dataset of 186 subjects (104 OCD and 82 healthy controls), and two longitudinal datasets of refractory patients receiving ventral capsule/ventral striatum DBS (14 OCD) and anterior capsulotomy (27 OCD). We developed a machine learning model predictive of OCD symptoms (indexed by the Yale-Brown Obsessive Compulsive Scale, Y-BOCS) based on functional connectivity profiles and used graphic measures of network communication to characterize treatment-induced profile changes. We applied a linear model on 2 levels treatments (DBS or capsulotomy) and outcome to identify whether pre-surgical network communication was associated with differential treatment outcomes. We identified 54 functional connectivities within fronto-subcortical networks significantly predictive of Y-BOCS score in patients across 3 independent cohorts, and observed a coexisting pattern of downregulated cortico-subcortical and upregulated cortico-cortical network communication commonly shared by DBS and capsulotomy. Furthermore, increased cortico-cortical communication at ventrolateral and centrolateral prefrontal cortices induced by DBS and capsulotomy contributed to improvement of mood and anxiety symptoms, respectively (p < 0.05). Importantly, pretreatment communication of ventrolateral and centrolateral prefrontal cortices were differentially predictive of mood and anxiety improvements by DBS and capsulotomy (effect sizes = 0.45 and 0.41, respectively). These findings unravel treatment-shared and treatment-specific network characteristics induced by DBS and capsulotomy, which may facilitate the search of potential evidence-based markers for optimally selecting among treatment options for a patient.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34703025     DOI: 10.1038/s41380-021-01358-w

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  60 in total

1.  Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder.

Authors:  B Nuttin; P Cosyns; H Demeulemeester; J Gybels; B Meyerson
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

2.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

Review 3.  Obsessive-Compulsive Disorder: Puzzles and Prospects.

Authors:  Trevor W Robbins; Matilde M Vaghi; Paula Banca
Journal:  Neuron       Date:  2019-04-03       Impact factor: 17.173

Review 4.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

5.  Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder.

Authors:  Darin D Dougherty; Lee Baer; G Rees Cosgrove; Edwin H Cassem; Bruce H Price; Andrew A Nierenberg; Michael A Jenike; Scott L Rauch
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

Review 6.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

7.  Capsulotomy for obsessive-compulsive disorder: long-term follow-up of 25 patients.

Authors:  Christian Rück; Andreas Karlsson; J Douglas Steele; Gunnar Edman; Björn A Meyerson; Kaj Ericson; Håkan Nyman; Marie Asberg; Pär Svanborg
Journal:  Arch Gen Psychiatry       Date:  2008-08

8.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

9.  Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.

Authors:  Luc Mallet; Mircea Polosan; Nematollah Jaafari; Nicolas Baup; Marie-Laure Welter; Denys Fontaine; Sophie Tezenas du Montcel; Jérôme Yelnik; Isabelle Chéreau; Christophe Arbus; Sylvie Raoul; Bruno Aouizerate; Philippe Damier; Stephan Chabardès; Virginie Czernecki; Claire Ardouin; Marie-Odile Krebs; Eric Bardinet; Patrick Chaynes; Pierre Burbaud; Philippe Cornu; Philippe Derost; Thierry Bougerol; Benoit Bataille; Vianney Mattei; Didier Dormont; Bertrand Devaux; Marc Vérin; Jean-Luc Houeto; Pierre Pollak; Alim-Louis Benabid; Yves Agid; Paul Krack; Bruno Millet; Antoine Pelissolo
Journal:  N Engl J Med       Date:  2008-11-13       Impact factor: 91.245

10.  Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trials.

Authors:  Benjamin Davidson; Clement Hamani; Jennifer S Rabin; Maged Goubran; Ying Meng; Yuexi Huang; Anusha Baskaran; Sachie Sharma; Miracle Ozzoude; Margaret Anne Richter; Anthony Levitt; Peter Giacobbe; Kullervo Hynynen; Nir Lipsman
Journal:  Mol Psychiatry       Date:  2020-05-14       Impact factor: 15.992

View more
  1 in total

Review 1.  A Systematic Review of Treatment Outcome Predictors in Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder.

Authors:  Hanyang Ruan; Yang Wang; Zheqin Li; Geya Tong; Zhen Wang
Journal:  Brain Sci       Date:  2022-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.